Participants who meet the diagnostic criteria of acute or chronic sinusitis will be included. [2,19,20] The study will include participants of any age, any race, and both sexes. 2.2.3 Types of interventions 2.2.3.1 Experimental interventions Schulz V, Hänsel R (2004). Rationale Phytotherapie: Ratgeber für Ärzte und Apotheker[ Rational Phytotherapy] (in German) (5thed.). Springer Science+Business Media. p.222. ISBN 978-3-540-00983-2. Padidėjusio jautrumo reakcijos (pvz., odos bėrimas, niežulys, veido patinimas, dusulys arba kraujotakos sutrikimas). We will use χ 2 tests to evaluate the statistical heterogeneity in the forest plot by RevMan V.5.3. According to the Cochrane Handbook, P values <0.1 will be identified as significant. [23] Furthermore, I 2 values will be analyzed to quantify the influence of the statistical heterogeneity. Heterogeneity will be classified into 4 categories according to the Cochrane Handbook as follows: 0% to 40%, might not be important; 30% to 60%, indicates moderate heterogeneity; 50% to 90%, represents substantial heterogeneity; and 75% to 100%, suggests considerable heterogeneity. 2.4.8 Assessment of reporting biases

Volker Schulz, Rudolf Hänsel, Mark Blumenthal, V. E. Tyler: Rational Phytotherapy. 5th ed., Springer, 2004, ISBN 978-3-540-40832-1, pp.207–208; 5th German edition, 2004, ISBN 3-540-00983-3, pp.222–223. In a randomised, double-blind, placebo-controlled study with 246 patients with chronic bronchitis, the long-term treatment over 6 months with ELOM-080 was investigated in comparison with placebo. In the process, ELOM-080 proved to be superior to placebo as regards effect: The intensity and frequency of acute deteriorations (exacerbations) of the chronic bronchitis were reduced statistically significantly and to a relevant extent with ELOM-080. By virtue of the treatment, an exacerbation peak that is typical of the season for the placebo group between the 2nd and 4th treatment month (usually December to February) did not occur in the ELOM-080 group. [35] [36] The quality of life of the patients, assessed according to their general condition and their impairment by coughing and sputum expectoration, was statistically significantly improved by the therapy with ELOM-080. Moreover, the need for antibiotics was clearly reduced under ELOM-080 in comparison with the sham treatment. In the process, ELOM-080 proved just as tolerable as placebo. The study has been considered by the Cochrane Airways Group in their annual review of the theme of mucolytics vs. placebo in chronic bronchitis and COPD. [37] Fürst R, Luong B, Thomsen J, Wittig T (July 2019). "ELOM-080 as Add-On Treatment for Respiratory Tract Diseases - A Review of Clinical Studies Conducted in China". Planta Medica. 85 (9–10): 745–754. doi: 10.1055/a-0942-1993. PMID 31167299.

3. Kaip vartoti Gelomyrtol forte

Among other things, stomach and upper abdominal pain as a result of taking Gelomyrtol capsules appear. Allergic reactions are also occasionally described. The manufacturer therefore recommends not taking it if: jeigu sergate bronchų astma, kokliušu arba kitokia kvėpavimo takų liga pasižyminčia padidėjusiu kvėpavimo sistemos jautrumu, Gelomyrtol forte galima vartoti tik gydytojui paskyrus. On the basis of the scientific literature, 4 professional medical societies recommend the use of ELOM-080 for treatment of sinusitis [16] [41] and coughing. [42] [43] Trade names [ edit ] Išgrynintų eukaliptų,saldžiųjų apelsinų,mirtų,citrinų eterinių aliejų mišinio(66:32:1:1)distiliatas Gottschlich S, Röschmann K, Candler H (July 2018). "Phytomedicines in Acute Rhinosinusitis: A Prospective, Non-interventional Parallel-Group Trial". Advances in Therapy. 35 (7): 1023–1034. doi: 10.1007/s12325-018-0736-7. PMID 29949046. S2CID 49434601.

Imajte u vidu da se ove informacije mogu odnositi i na lekove koje više ne pijete, kao i na lekove koje planirate da uzimate u budućnosti. Obavestite svog lekara ili farmaceuta ako uzimate, ili ste do nedavno uzimali neki drugi lek, uključujući i lek koji se nabavlja bez lekarskog recepta. Išgrynintų eukaliptų, saldžiųjų apelsinų, mirtų ir citrinų eterinių aliejų mišinio (66:32:1:1) distiliatas Veiklioji medžiaga. Vienoje skrandyje neirioje minkštojoje kapsulėje yra 300 mg išgrynintų eukaliptų, saldžiųjų apelsinų, mirtų ir citrinų eterinių aliejų mišinio (66:32:1:1) distiliato.

We will use a funnel plot to assess the reporting bias if ten or more studies are included. [23] 2.5 Data synthesis Vienoje skrandyje neirioje minkštojoje kapsulėje yra 300 mg išgrynintų eukaliptų, saldžiųjų apelsinų, mirtų ir citrinų eterinių aliejų mišinio (66:32:1:1) distiliato. Skystina tirštas gleives bei veikia sekreciją, stimuliuoja ir lengvina atsikosėjimą. Tyrimų su gyvūnais metu, nustatyta, kad gleivių išsiskyrimas sustiprėja peroraliai pavartojus klinikines preparato dozes. Tai yra būtina sąlyga preparato, kaip sekretolitiko, vartojimui. Be sekretolitinio poveikio, tolimesniuose tyrimuose su gyvūnais ir in vitro tyrimų metu vartojant dideles dozes nustatytas antimikrobinis poveikis. Be to, tinkamuose modeliuose stebėtas priešuždegiminis poveikis. Apirbendrinus, visos šios savybės svarbio Gelomyrtol ir Gelomyrtol forte poveikiui. PubMed, EMBASE, the Cochrane Library, the Web of Science, the Chinese National Knowledge Infrastructure Database, the Chinese Biomedical Literature Database, the Wan Fang Database, and the Chongqing VIP Chinese Science, and Technology Periodical Database will be searched from their commencement until July 2020. Randomized controlled trials of Gelomyrtol for acute or chronic sinusitis will be selected in any language. Primary outcomes will include the Sino-Nasal Outcome Test-22 (SNOT-22) score, quality of life score as measured by SF-36, and the change in computed tomography (CT) score. Study selection, data extraction, and deviation risk assessment will be carried out by 2 investigators independently. RevMan V.5.3 software will be used to analyze the study data. Results: Matthys H, de Mey C, Carls C, Ryś A, Geib A, Wittig T (August 2000). "Efficacy and tolerability of myrtol standardized in acute bronchitis. A multi-centre, randomised, double-blind, placebo-controlled parallel group clinical trial vs. cefuroxime and ambroxol". Arzneimittel-Forschung. Editio Cantor Verlag. 50 (8): 700–11. doi: 10.1055/s-0031-1300276. PMID 10994153. S2CID 39472417.

Trys pagrindinės medžiagos 1,8 cineolas, limonenas ir α‑pinenas yra hiroksilinami, o vėliau vyksta dalinė arba pilna gliukuronidacija. Limonenas daugiausiai transformuojams į dihidroperilo rūgštį, perilo rūgštį ir limoneno 1,2‑diolį. Indications: GeloMyrtol Forte is a herbal medicine, the active substance is obtained from the essential oils of plants. For liquefying secretions in case of sinusitis and bronchitis. You must talk to a doctor if you do not feel better or if you feel worse after 10 days. cDepartment of Gastroenterology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu 610072, Sichuan Province, People's Republic of China.It is also suitable Gelomyrtol, used to treat bronchitis. The herbal expectorant can also be combined with antibiotics. Always ask your doctor or pharmacist about the tolerance and effectiveness of GeloMyrtol. What is bronchitis? Federspil P, Wulkow R, Zimmermann T (January 1997). "Wirkung von Myrtol standardisiert* bei der Therapie der akuten Sinusitis - Ergebnisse einer doppelblinden, randomisierten Multicenterstudie gegen Plazebo" [Effects of standardized Myrtol in therapy of acute sinusitis--results of a double-blind, randomized multicenter study compared with placebo]. Laryngo- Rhino- Otologie (in German). Georg Thieme Verlag. 76 (1): 23–7. doi: 10.1055/s-2007-997381. PMID 9156505. S2CID 72740124.